History
A small shell that tried Mexican and Nevada mining and a pharma asset, then in 2025 bought AI software with new shares, funded by a related-party lender.
2011-2013: A shell looks to Mexico
In June 2011 the company, filing as International Gold Corp., signed a non-binding letter of intent to buy Cormack Capital Group LLC, whose Mexican subsidiary held mining concessions of about 15,980 hectares in Chihuahua. The price was 25,000,000 new shares plus $150,000 cash. In July it became a definitive agreement, with the cash to be treated as a 5% secured demand loan if the deal did not close. Closing still depended on due diligence, approvals and an interim financing.
In September 2011 director Robert Baker took over 2,500,000 shares and came to own 5,000,000 of 6,250,000 outstanding shares, or 80%. The filings do not say what became of the Cormack deal. The share count rose to 11,509,000 by the end of 2013, but the record does not explain how.
2014-2021: Goldfield Bonanza
In October 2014 the company signed an option with Lode-Star Gold (LSG) on the Goldfield Bonanza property in Nevada. Issuing 35,000,000 shares, deemed worth $0.02 each ($700,000), earned a 20% interest. A further 60% required funding all property spending and paying LSG $5 million through a royalty on the metal produced. The deal closed on December 11, 2014. LSG became the controlling stockholder, and the accounts treated it as a reverse acquisition. Baker resigned as President and CEO, and Mark Walmesley took over. A settlement ended Baker's consulting agreement, leaving $20,250 owed to him. The company described itself as a shell before the deal.
In August 2016 management said its 2015 annual and March 2016 quarterly accounts could no longer be relied on, because option fees owed to LSG had not been accrued: $123,913 at the end of 2015 and $148,901 at March 2016. LSG deferred the fees to January 2017. The record is then quiet until November 2019, when the option was amended. The 60% was split into two 30% steps, each needing a $5 million royalty payment, which raised the total price for that 60% from $5 million to $10 million.
2021-2022: Pharma detour and unwinding
On December 28, 2021 the company, then called Lode-Star Mining, bought from Sapir Pharmaceuticals its assets for a stabilised EGCG molecule formulation for drug development. Payment was one million Series A preferred shares valued at $1.00 each, plus a 5% royalty on revenue. In January 2022 the Goldfield option was terminated. The company returned its 20% interest, and LSG forgave about $2.224 million owed, keeping its 35,000,000 shares.
The reversal came in June 2022. The Sapir deal was rescinded because the company could not develop the business. The LSG debt was reinstated, and $2,601,207.55 owed to LSG, Lonnie Humphries and Walmesley was converted into 70,302,906 shares at $0.037. LSG received 62,769,918 of them. Shares outstanding rose from about 50.6 million to 120.9 million over 2022.
2025-2026: Pivot to AI software
A February 2025 filing said the company had had no operations since the 2022 settlement. On February 14, 2025 it closed the purchase of AI software and technology from Tarka L'Herpiniere, to be named FinTradeSherpa, for 227,000,000 new shares. It also took an exclusive licence from Predictive Technology for $440,000 at $5,000 a month, and agreed to pay Arcterix $123,000 after an equity financing of at least $200,000. Separately, $169,644.71 owed to LSG was converted into 1,357,158 shares.
The 227,000,000 shares were actually issued on January 23, 2026, leaving 351,054,600 outstanding. Humphries, Walmesley's spouse, held 29.01%. Management said the first development phase was mostly complete and beta testing was next. No revenue had been reported.
On April 8, 2026 the company signed an interim note with LSG, its largest shareholder and largest current debt holder. It covered $74,811.50 lent as of March 30, 2026 plus further advances, at 15.0015% a year, maturing March 31, 2028. It was secured over the company's "Alpha-Optimus" project intellectual property. The filings do not say how that project relates to the FinTradeSherpa software. As of April 14, 2026, going-concern doubt had been noted in earlier audit reports, and the full note documents were not yet filed.
Written from the 13 story beats below (2011 to 14 Apr 2026), which come from the company's own announcements and filings.